Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In severe osteoarthritis, the limiting problem is often structural joint degeneration
In contrast, a meta-analysis by Silverii et al
These reduce per-month costs but increase total upfront investment
Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2
Eligible individuals or their dependents can enroll after the open enrollment, typically due to an event such as marriage, birth, adoption, or other qualifying events as defined by law
Patients Medicals position: We do not position functional medicine as an alternative to conventional medicine
US$ 22.73
US$ 25.38
US$ 25.87
US$ 24.47
US$ 28.93
US$ 24.55
US$ 25.22
US$ 27.76
